Response to Comment on Gan et al. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2020;43:1948-1957

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes care 2020-12, Vol.43 (12), p.E202-E203
Hauptverfasser: Gan, Sushrima, Dawed, Adem Y., Donnelly, Louise A., Nair, Anand T. N., Palmer, Colin N. A., Mohan, Viswanathan, Pearson, Ewan R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page E203
container_issue 12
container_start_page E202
container_title Diabetes care
container_volume 43
creator Gan, Sushrima
Dawed, Adem Y.
Donnelly, Louise A.
Nair, Anand T. N.
Palmer, Colin N. A.
Mohan, Viswanathan
Pearson, Ewan R.
description
doi_str_mv 10.2337/dci20-0049
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7770275</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2463106150</sourcerecordid><originalsourceid>FETCH-LOGICAL-c295t-53b93853673d8a880e9ada745c7c89a4786a863267f7684d9f1978c4350d74713</originalsourceid><addsrcrecordid>eNqNks1uEzEUhUcIREthwwMgS2wqYIJnbI_tIiFFaQlIqYjSoC5HjucOcTVjB9tpFV6cLU5Sws-Kla_s7xwd2yfLnhd4UBLC3zbalDjHmMoH2XEhCcsZo-JhdowLKnMmZXmUPQnhBieECvE4OyKkLIQU7Dj7MYOwcjYAig6NXN-DjchZNFYWQUSqG6CLtjVa6Q1yLbp0DXiLzo1aQISA5h5U3GoCOp9Oc2reoKvxZJ6XaVC2QePJNC9mQ2Qsul6aCLvNYTDJfaqi2QmvTVweHM_QEF1tQoQ-HWs0g1sDdzvVJUSVK6u6TTBhm2WWdl1vvkOTgtvoXdelce6N6sLgd8SR8oBKXOJ3lJwVkoq8kIw_zR61iYNn9-tJ9uXDxXz0MZ98Hn8aDSe5LiWLOSMLSQQjFSeNUEJgkKpRnDLNtZCKclEpUZGy4i2vBG1kW0guNCUMN5zygpxk7_e-q_Wih0anG3vV1StveuU3tVOm_vvEmmX91d3WnHNccpYMTu8NvPu2hhDr3gQNXacsuHWoS1qRAlcFwwl9-Q9649Y-vdiW4oQSyQRN1Ks9pb0LwUN7CFPgetunetenetunBL_4M_4B_VWgBIg9cAcL1wadvlTDAUuNYxKL1MY04WpkYvpVZ0dubWOSvv5_KfkJQH7jqA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2473439584</pqid></control><display><type>article</type><title>Response to Comment on Gan et al. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2020;43:1948-1957</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Gan, Sushrima ; Dawed, Adem Y. ; Donnelly, Louise A. ; Nair, Anand T. N. ; Palmer, Colin N. A. ; Mohan, Viswanathan ; Pearson, Ewan R.</creator><creatorcontrib>Gan, Sushrima ; Dawed, Adem Y. ; Donnelly, Louise A. ; Nair, Anand T. N. ; Palmer, Colin N. A. ; Mohan, Viswanathan ; Pearson, Ewan R.</creatorcontrib><identifier>ISSN: 0149-5992</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/dci20-0049</identifier><identifier>PMID: 33218985</identifier><language>eng</language><publisher>ALEXANDRIA: Amer Diabetes Assoc</publisher><subject>Clinical trials ; Diabetes Mellitus ; Dipeptidyl-Peptidase IV Inhibitors - therapeutic use ; e-Letters: Comments and Responses ; Endocrinology &amp; Metabolism ; Humans ; Life Sciences &amp; Biomedicine ; Randomized Controlled Trials as Topic ; Science &amp; Technology ; Sodium-Glucose Transporter 2 Inhibitors - therapeutic use ; Systematic review</subject><ispartof>Diabetes care, 2020-12, Vol.43 (12), p.E202-E203</ispartof><rights>Copyright American Diabetes Association Dec 1, 2020</rights><rights>2020 by the American Diabetes Association 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>0</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000590854800006</woscitedreferencesoriginalsourcerecordid><cites>FETCH-LOGICAL-c295t-53b93853673d8a880e9ada745c7c89a4786a863267f7684d9f1978c4350d74713</cites><orcidid>0000-0001-9237-8585 ; 0000-0002-6415-6560 ; 0000-0001-5038-6210 ; 0000-0003-0224-2428</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33218985$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gan, Sushrima</creatorcontrib><creatorcontrib>Dawed, Adem Y.</creatorcontrib><creatorcontrib>Donnelly, Louise A.</creatorcontrib><creatorcontrib>Nair, Anand T. N.</creatorcontrib><creatorcontrib>Palmer, Colin N. A.</creatorcontrib><creatorcontrib>Mohan, Viswanathan</creatorcontrib><creatorcontrib>Pearson, Ewan R.</creatorcontrib><title>Response to Comment on Gan et al. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2020;43:1948-1957</title><title>Diabetes care</title><addtitle>DIABETES CARE</addtitle><addtitle>Diabetes Care</addtitle><subject>Clinical trials</subject><subject>Diabetes Mellitus</subject><subject>Dipeptidyl-Peptidase IV Inhibitors - therapeutic use</subject><subject>e-Letters: Comments and Responses</subject><subject>Endocrinology &amp; Metabolism</subject><subject>Humans</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Science &amp; Technology</subject><subject>Sodium-Glucose Transporter 2 Inhibitors - therapeutic use</subject><subject>Systematic review</subject><issn>0149-5992</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><sourceid>EIF</sourceid><recordid>eNqNks1uEzEUhUcIREthwwMgS2wqYIJnbI_tIiFFaQlIqYjSoC5HjucOcTVjB9tpFV6cLU5Sws-Kla_s7xwd2yfLnhd4UBLC3zbalDjHmMoH2XEhCcsZo-JhdowLKnMmZXmUPQnhBieECvE4OyKkLIQU7Dj7MYOwcjYAig6NXN-DjchZNFYWQUSqG6CLtjVa6Q1yLbp0DXiLzo1aQISA5h5U3GoCOp9Oc2reoKvxZJ6XaVC2QePJNC9mQ2Qsul6aCLvNYTDJfaqi2QmvTVweHM_QEF1tQoQ-HWs0g1sDdzvVJUSVK6u6TTBhm2WWdl1vvkOTgtvoXdelce6N6sLgd8SR8oBKXOJ3lJwVkoq8kIw_zR61iYNn9-tJ9uXDxXz0MZ98Hn8aDSe5LiWLOSMLSQQjFSeNUEJgkKpRnDLNtZCKclEpUZGy4i2vBG1kW0guNCUMN5zygpxk7_e-q_Wih0anG3vV1StveuU3tVOm_vvEmmX91d3WnHNccpYMTu8NvPu2hhDr3gQNXacsuHWoS1qRAlcFwwl9-Q9649Y-vdiW4oQSyQRN1Ks9pb0LwUN7CFPgetunetenetunBL_4M_4B_VWgBIg9cAcL1wadvlTDAUuNYxKL1MY04WpkYvpVZ0dubWOSvv5_KfkJQH7jqA</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Gan, Sushrima</creator><creator>Dawed, Adem Y.</creator><creator>Donnelly, Louise A.</creator><creator>Nair, Anand T. N.</creator><creator>Palmer, Colin N. A.</creator><creator>Mohan, Viswanathan</creator><creator>Pearson, Ewan R.</creator><general>Amer Diabetes Assoc</general><general>American Diabetes Association</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9237-8585</orcidid><orcidid>https://orcid.org/0000-0002-6415-6560</orcidid><orcidid>https://orcid.org/0000-0001-5038-6210</orcidid><orcidid>https://orcid.org/0000-0003-0224-2428</orcidid></search><sort><creationdate>20201201</creationdate><title>Response to Comment on Gan et al. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2020;43:1948-1957</title><author>Gan, Sushrima ; Dawed, Adem Y. ; Donnelly, Louise A. ; Nair, Anand T. N. ; Palmer, Colin N. A. ; Mohan, Viswanathan ; Pearson, Ewan R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c295t-53b93853673d8a880e9ada745c7c89a4786a863267f7684d9f1978c4350d74713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Clinical trials</topic><topic>Diabetes Mellitus</topic><topic>Dipeptidyl-Peptidase IV Inhibitors - therapeutic use</topic><topic>e-Letters: Comments and Responses</topic><topic>Endocrinology &amp; Metabolism</topic><topic>Humans</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Science &amp; Technology</topic><topic>Sodium-Glucose Transporter 2 Inhibitors - therapeutic use</topic><topic>Systematic review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gan, Sushrima</creatorcontrib><creatorcontrib>Dawed, Adem Y.</creatorcontrib><creatorcontrib>Donnelly, Louise A.</creatorcontrib><creatorcontrib>Nair, Anand T. N.</creatorcontrib><creatorcontrib>Palmer, Colin N. A.</creatorcontrib><creatorcontrib>Mohan, Viswanathan</creatorcontrib><creatorcontrib>Pearson, Ewan R.</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gan, Sushrima</au><au>Dawed, Adem Y.</au><au>Donnelly, Louise A.</au><au>Nair, Anand T. N.</au><au>Palmer, Colin N. A.</au><au>Mohan, Viswanathan</au><au>Pearson, Ewan R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Response to Comment on Gan et al. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2020;43:1948-1957</atitle><jtitle>Diabetes care</jtitle><stitle>DIABETES CARE</stitle><addtitle>Diabetes Care</addtitle><date>2020-12-01</date><risdate>2020</risdate><volume>43</volume><issue>12</issue><spage>E202</spage><epage>E203</epage><pages>E202-E203</pages><issn>0149-5992</issn><eissn>1935-5548</eissn><cop>ALEXANDRIA</cop><pub>Amer Diabetes Assoc</pub><pmid>33218985</pmid><doi>10.2337/dci20-0049</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0001-9237-8585</orcidid><orcidid>https://orcid.org/0000-0002-6415-6560</orcidid><orcidid>https://orcid.org/0000-0001-5038-6210</orcidid><orcidid>https://orcid.org/0000-0003-0224-2428</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0149-5992
ispartof Diabetes care, 2020-12, Vol.43 (12), p.E202-E203
issn 0149-5992
1935-5548
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7770275
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Clinical trials
Diabetes Mellitus
Dipeptidyl-Peptidase IV Inhibitors - therapeutic use
e-Letters: Comments and Responses
Endocrinology & Metabolism
Humans
Life Sciences & Biomedicine
Randomized Controlled Trials as Topic
Science & Technology
Sodium-Glucose Transporter 2 Inhibitors - therapeutic use
Systematic review
title Response to Comment on Gan et al. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2020;43:1948-1957
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T11%3A30%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Response%20to%20Comment%20on%20Gan%20et%20al.%20Efficacy%20of%20Modern%20Diabetes%20Treatments%20DPP-4i,%20SGLT-2i,%20and%20GLP-1RA%20in%20White%20and%20Asian%20Patients%20With%20Diabetes:%20A%20Systematic%20Review%20and%20Meta-analysis%20of%20Randomized%20Controlled%20Trials.%20Diabetes%20Care%202020;43:1948-1957&rft.jtitle=Diabetes%20care&rft.au=Gan,%20Sushrima&rft.date=2020-12-01&rft.volume=43&rft.issue=12&rft.spage=E202&rft.epage=E203&rft.pages=E202-E203&rft.issn=0149-5992&rft.eissn=1935-5548&rft_id=info:doi/10.2337/dci20-0049&rft_dat=%3Cproquest_pubme%3E2463106150%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2473439584&rft_id=info:pmid/33218985&rfr_iscdi=true